Mirae Asset Global ETFs Holdings
JAZZ icon

Mirae Asset Global ETFs Holdings’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.19M Sell
13,222
-3,517
-21% -$770K ﹤0.01% 1033
2026
Q1 		$3.16M Sell
16,739
-6,030
-26% -$1.05M ﹤0.01% 988
2025
Q4 		$3.87M Sell
22,769
-8,920
-28% -$1.37M 0.01% 885
2025
Q3 		$4.18M Sell
31,689
-19,435
-38% -$2.33M 0.01% 853
2025
Q2 		$5.43M Sell
51,124
-1,351
-3% -$147K 0.01% 734
2025
Q1 		$6.51M Sell
52,475
-8,604
-14% -$1.12M 0.01% 684
2024
Q4 		$7.52M Sell
61,079
-3,604
-6% -$425K 0.02% 652
2024
Q3 		$7.21M Sell
64,683
-5,070
-7% -$556K 0.02% 663
2024
Q2 		$7.44M Buy
+69,753
New +$7.67M 0.02% 627

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's JAZZ Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Jazz Pharmaceuticals (JAZZ) stake by 21% in Q2 2026, selling an estimated $770K and leaving 13,222 shares worth $3.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1033.

Mirae Asset Global ETFs Holdings first reported a position in JAZZ in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.52M in Q4 2024. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 13,222 shares of Jazz Pharmaceuticals worth $3.19M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 3,517 Jazz Pharmaceuticals shares in Q2 2026, an estimated $770K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1033 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Jazz Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Jazz Pharmaceuticals position peaked at $7.52M in Q4 2024.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.